If you are caring for someone with dementia or managing your own brain health, the short answer is yes, you should probably get another COVID shot, and the best time is now if it has been at least two months since your last dose. The CDC recommends the 2025–2026 COVID-19 vaccine for everyone ages six months and older, with particular emphasis on adults 65 and older and those at high risk for severe illness. For people living with dementia or other neurological conditions, COVID-19 poses outsized dangers: prolonged hospitalization, accelerated cognitive decline, and delirium that can permanently worsen functioning. A 78-year-old with moderate Alzheimer’s, for instance, may never regain baseline cognition after a severe COVID hospitalization, making prevention far more consequential than it is for the general population. Yet fewer people than ever are rolling up their sleeves. As of February 2026, only 17.5% of U.S. adults had received the updated 2025–2026 vaccine, and even among adults 65 and older, the uptake sits at just 30.8%.
That means roughly seven out of ten older adults, the group most vulnerable to severe outcomes, are currently unprotected by the latest formulation. The phenomenon has a name: booster fatigue. People are tired of repeated shots, skeptical about whether another dose matters, and confused by shifting guidance. This article breaks down the current recommendations, what the effectiveness data actually shows, why the timing of your shot matters, what side effects to realistically expect, and how to make a practical decision, especially if you are a caregiver navigating this for someone who cannot advocate for themselves. This is not a piece designed to shame anyone into compliance. Booster fatigue is real and understandable. But the stakes for people with dementia and brain health vulnerabilities are different from the stakes for a healthy 30-year-old, and the data reflects that difference clearly. Understanding what the numbers say, and what they do not say, is the first step toward making a decision grounded in evidence rather than exhaustion.
Table of Contents
- Why Are So Many People Skipping COVID Boosters, and Does It Matter for Brain Health?
- What the Effectiveness Data Actually Shows, and Where It Falls Short
- Timing Your Shot for Maximum Protection
- What Side Effects to Expect and How to Manage Them in People With Dementia
- The Cost Question and Access Barriers for Older Adults
- Three Vaccines Are Available, and They Are Not Identical
- What Comes Next and Why Annual Decisions May Be the New Normal
- Conclusion
- Frequently Asked Questions
Why Are So Many People Skipping COVID Boosters, and Does It Matter for Brain Health?
The reasons people give for skipping boosters are remarkably consistent. According to a study published in PubMed, 39.5% of people who declined a booster cited a prior COVID infection as their reason, believing natural immunity was sufficient. Another 31.5% were worried about side effects, 28.6% did not believe the booster provided additional protection, 23.4% had general safety concerns, and 23.1% doubted the vaccine would prevent infection at all. These are not fringe positions. They reflect a population that has been asked to get vaccinated repeatedly for over five years and is genuinely questioning whether the next shot changes anything. For context, the 2024–2025 season saw adult uptake stall at roughly 21%, the lowest since COVID vaccines became available and barely half the flu vaccine uptake of 42% during the same period, according to data published in the New England Journal of Medicine. The trend is moving in the wrong direction.
Among children, the picture is even starker: only 9.0% were up to date as of late February 2026. Here is where brain health enters the equation. COVID-19 is not just a respiratory illness. Research has consistently linked severe infections to neuroinflammation, microclotting in cerebral blood vessels, and measurable declines in cognitive function even months after recovery. For someone already living with vascular dementia, Alzheimer’s disease, or mild cognitive impairment, a severe COVID infection can accelerate decline in ways that are not reversible. The calculus for this population is fundamentally different. A healthy 40-year-old who skips a booster and catches a mild case will likely recover fully. An 82-year-old with Lewy body dementia who ends up hospitalized may not come home to the same level of independence.
What the Effectiveness Data Actually Shows, and Where It Falls Short
The updated 2025–2026 monovalent vaccines, which target the JN.1 and KP.2 variants, have shown strong results in laboratory testing: 80–95% neutralization in assays and 84% protection against hospitalization in adults 65 and older, according to Medical Daily’s review of the clinical data. Those are encouraging numbers, particularly for the demographic most relevant to dementia caregiving. However, real-world effectiveness tells a more nuanced story. Data from the IVY Network study published in PMC found that the 2024–2025 vaccines provided 57.5% effectiveness against hospitalization and death at four weeks post-vaccination, but that protection declined to 37.4% at 60 days, 29.0% at 90 days, and just 22.5% at 120 days. A separate Veterans Affairs study published in the New England Journal of Medicine estimated effectiveness at 45% for immunocompetent adults 65 and older and 40% for immunocompromised individuals in the 7–119 day window after vaccination.
The protection is real, but it is not permanent, and it is not absolute. this waning pattern is important for caregivers to understand. If you are trying to time a booster for maximum protection during a period of heightened risk, such as a holiday season, a planned surgery, or a move into a care facility, you want the shot roughly two to four weeks before that exposure window. Waiting until after a wave has already peaked in your area means the vaccine’s strongest period of protection may arrive too late. And if the person you are caring for is immunocompromised, the effectiveness floor is lower, which makes layered protections like masking in crowded medical settings and good ventilation more important, not less.
Timing Your Shot for Maximum Protection
The CDC’s current guidance is straightforward on paper: get a single dose of the 2025–2026 vaccine at least two months after any previous COVID-19 vaccine dose. If you are opting for the newer Moderna mNexspike formulation, the recommended interval is at least three months. And if the person in question has recently recovered from a COVID infection, waiting three to four months after that infection will maximize the immune response from the next dose. In practice, timing decisions are often more complicated for dementia caregivers. Consider someone caring for a parent with moderate Alzheimer’s who lives in an assisted living facility. The facility may have its own vaccination schedule, the parent may have difficulty communicating symptoms of a recent mild infection, and coordinating medical appointments can be logistically demanding.
In these situations, it helps to work backward from known risk periods. Respiratory virus season in most of the United States intensifies from November through February. Getting a booster in September or October positions the strongest window of protection over the highest-risk months. If you missed that window, getting vaccinated now still provides meaningful protection, just with the understanding that peak efficacy is in the first one to two months. For individuals receiving additional doses due to immunocompromised status, the CDC allows each subsequent dose at least two months apart. This applies to many people in the dementia care population, including those on certain medications for autoimmune conditions or those undergoing cancer treatment alongside their cognitive decline. If you are unsure whether your family member qualifies for additional doses, their primary care physician or neurologist can clarify based on their medication list and overall immune function.
What Side Effects to Expect and How to Manage Them in People With Dementia
The most common side effects of COVID boosters are injection site soreness, fatigue, headache, muscle pain, and chills. These typically appear within 12 to 24 hours and resolve within one to three days. Notably, side effects tend to be milder with booster doses than with the original primary series, according to Harvard Health. For most healthy adults, this is a minor inconvenience. For someone living with dementia, however, even mild side effects can be disorienting and distressing. A person who cannot understand why they suddenly feel achy and feverish may become agitated, confused, or resistant to care. Caregivers should plan for 24 to 48 hours of closer monitoring after a booster.
Keep acetaminophen available if the care recipient’s physician approves it for symptom management. Maintain familiar routines as much as possible, since disruption and discomfort together can trigger behavioral symptoms in people with cognitive impairment. It can also help to schedule the shot in the morning, so the worst of any reaction occurs during waking hours when supervision is easier. The tradeoff is worth stating plainly: one to three days of manageable discomfort versus the risk of a severe COVID infection that could mean weeks of hospitalization, potential delirium, and lasting cognitive damage. For someone whose cognitive reserve is already diminished, the math strongly favors vaccination. That said, if a previous dose caused an unusually severe reaction, such as a high fever lasting more than three days or significant swelling beyond the injection site, discuss it with a physician before the next dose. Allergic reactions are rare but do occur, and a documented history should inform, not necessarily prevent, future vaccination.
The Cost Question and Access Barriers for Older Adults
Cost should not be a barrier to vaccination for most people. COVID-19 vaccines remain free with most insurance, including private plans, Medicare Part B, and Medicaid, when administered by an in-network provider. Under the Affordable Care Act, this coverage is required through at least the end of 2026, according to KFF Health News. For the Medicare population, which encompasses the vast majority of dementia patients, this means no out-of-pocket cost at a participating pharmacy or clinic. Without insurance, the picture is different. Expect to pay between $150 and $250 out of pocket, according to estimates from GoodRx and BetterCare. That is a significant sum, particularly for uninsured older adults living on fixed incomes.
However, many state and local immunization programs still offer free or low-cost vaccines regardless of insurance status. Area Agencies on Aging, local health departments, and federally qualified health centers are good starting points for finding subsidized access. A less discussed barrier is logistical. For someone with moderate to advanced dementia, getting to a pharmacy for a vaccination is not trivial. They may need transportation, a companion who can provide consent and manage any behavioral reactions in a public setting, and a provider willing to take extra time with a patient who may be confused or uncooperative. Some home health agencies and visiting nurse programs can administer vaccines at home, and it is worth asking about this option. The shot itself takes seconds. The infrastructure around getting a cognitively impaired person to that moment can take hours of planning.
Three Vaccines Are Available, and They Are Not Identical
As of the current season, three COVID-19 vaccines are authorized or approved in the United States: Moderna Spikevax for ages six months and older, Moderna mNexspike for ages 12 and older, and Pfizer-BioNTech Comirnaty for ages five and older. Pfizer is no longer authorized for children ages six months through four years. For most older adults, the practical choice comes down to whichever vaccine is available at their pharmacy or clinic, and all three target the same variant lineage.
The one distinction worth noting is that the Moderna mNexspike formulation requires a longer interval, at least three months since the last COVID vaccine dose, compared to the two-month minimum for the other options. If timing is a factor, for example if you want to get vaccinated before an upcoming surgery or care facility transition, this difference may influence which vaccine you request. Your pharmacist can confirm which formulations they carry and help you determine the appropriate interval based on vaccination history.
What Comes Next and Why Annual Decisions May Be the New Normal
The trajectory of COVID vaccination is starting to resemble flu vaccination: an annual shot, updated to match circulating variants, with uptake that depends more on habit and trust than on mandates or emergency urgency. The challenge is that COVID still kills and disables at higher rates than influenza, particularly among older adults and those with neurological vulnerabilities. The gap between the severity of the threat and the public’s willingness to act on it is widening.
For dementia caregivers, the practical takeaway is to build COVID vaccination into the same annual rhythm as the flu shot and any pneumonia or shingles vaccines that are due. Talk to your loved one’s physician each fall about which respiratory vaccines are recommended, get them scheduled together when possible to minimize trips, and document everything in a care binder or shared health record. The science will continue to evolve, new formulations will emerge, and recommendations will shift. What will not change is that people with dementia remain among the most vulnerable to severe respiratory infections, and that prevention, however imperfect, remains far easier than treatment.
Conclusion
Booster fatigue is a legitimate response to years of pandemic disruption, shifting guidance, and repeated asks. But for people living with dementia and their caregivers, the decision to vaccinate is not about pandemic politics or personal preference. It is a clinical calculation. The current vaccines offer meaningful, if time-limited, protection against severe illness and hospitalization, with side effects that are generally mild and manageable. The data shows 84% protection against hospitalization for adults 65 and older with the latest formulation, and the cost is covered by insurance for the vast majority of Medicare beneficiaries.
If it has been more than two months since the last COVID vaccine and more than three to four months since a known COVID infection, now is a reasonable time to schedule the next dose. Coordinate with your loved one’s medical team, plan for a day or two of monitoring afterward, and layer in common-sense precautions like good ventilation and hand hygiene during peak respiratory season. You do not need to chase every headline or agonize over every new variant name. You need a practical plan, updated once a year, that accounts for the specific vulnerabilities of the person in your care. That is not fatigue. That is good caregiving.
Frequently Asked Questions
Can someone with advanced dementia safely receive a COVID booster?
In most cases, yes. The vaccine itself is safe regardless of cognitive status. The main considerations are managing potential behavioral responses to the injection and monitoring for side effects in someone who may not be able to articulate symptoms. Discuss specific concerns with their physician, especially if the person has a history of severe allergic reactions.
Does a prior COVID infection mean my family member can skip the booster?
Prior infection does provide some natural immunity, but it wanes over time just as vaccine-derived immunity does. The CDC still recommends vaccination even after infection, with a suggested wait of three to four months after recovery to maximize the immune boost from the next dose.
Should I get the booster at the same time as the flu shot?
Yes, co-administration is considered safe and is commonly done. Getting both at the same visit reduces the number of trips, which is especially valuable for caregivers managing transportation and behavioral challenges.
How do I know which vaccine my family member should get?
All three available vaccines target the same variant lineage and offer comparable protection. The main practical differences are age eligibility and the required interval since the last dose. Your pharmacist can help determine the best option based on what is in stock and your family member’s vaccination history.
What if my loved one becomes agitated or combative during the injection?
This is not uncommon in moderate to advanced dementia. Strategies include having a familiar caregiver present, using calm and simple language, offering a comforting item or distraction, and choosing a quieter time of day when the person tends to be most cooperative. Some home health services can administer the vaccine in a familiar environment, which often reduces distress.
